Suchergebnisse
Suchergebnisse:
Our mission at Spark Therapeutics is to unlock the power of gene therapy to accelerate healthcare transformation. We have built a fully integrated company, combining our proprietary adeno-associated viral (AAV) gene therapy platform with excellence in R&D, manufacturing and commercial operations.
- We are Spark
At Spark Therapeutics, we’re working to unlock the power of...
- Our Products
Spark Therapeutics, Inc. 3737 Market Street Philadelphia, PA...
- Our scientific platform & programs
Spark Therapeutics is developing SPK-3006, an...
- Healthcare professionals
References: Berger W, Kloeckener-Gruissem B, Neidhardt J....
- Join the Spark team
The Truths We Live By. We proudly say, “We are Spark.”...
- Contact Us
For Medical Inquiries Call: 1-866-MI-SPARK (1-866-647-7275)...
- We are Spark
Products and pipeline. The company has 3 gene therapy product candidates in clinical development: (i) SPK-8011, a candidate in the SPK-FVIII program for hemophilia A; (ii) SPK-8016, a product candidate for the hemophilia A inhibitor market; and (iii) SPK-7001, targeting choroideremia, or CHM.
Spark Therapeutics was founded in 2013 and became a Member of the Roche Group in 2019. The organisation is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies for genetic diseases, including inherited retinal disorders, haemophilia, lysosomal storage disorders and neurodegenerative diseases.
23. Feb. 2022 · Spark Therapeutics is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies. Founded in 2013, Spark Therapeutics is the first company in the U.S. to receive FDA approval of a gene therapy for a genetic disease.
Spark Therapeutics, Inc. | 87,207 followers on LinkedIn. Our mission is to unlock the power of gene therapy to accelerate healthcare transformation. | At Spark® Therapeutics, we believe in...
17. Dez. 2019 · Spark Therapeutics is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies. The company challenges the inevitability of...